Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Den Private Smerteklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.8% 4.2% 2.7% 1.6% 1.8% 1.5% 16.0% 15.7%   Credit score (0-100)   47 50 62 76 72 75 11 11   Credit rating   BBB BBB BBB A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 10.3 3.2 19.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   11,685 13,009 0 0 0 0 0 0   Gross profit   9,576 10,598 9,247 10,929 10,620 10,445 0.0 0.0   EBITDA   1,305 2,016 700 1,831 1,677 1,807 0.0 0.0   EBIT   1,282 1,936 619 1,751 1,649 1,807 0.0 0.0   Pre-tax profit (PTP)   1,269.5 1,928.3 554.5 1,736.2 1,677.0 1,805.0 0.0 0.0   Net earnings   990.1 1,504.0 431.1 1,354.2 1,310.5 1,405.5 0.0 0.0   Pre-tax profit without non-rec. items   1,270 1,928 555 1,736 1,677 1,805 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   117 82.6 48.4 28.6 0.0 0.0 0.0 0.0   Shareholders equity total   1,286 1,890 821 1,776 1,736 1,842 417 417   Interest-bearing liabilities   494 383 999 699 0.8 1,718 0.0 0.0   Balance sheet total (assets)   3,351 4,199 3,704 4,560 4,049 6,260 417 417   Net Debt   217 -408 879 391 -309 862 -417 -417     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   11,685 13,009 0 0 0 0 0 0   Net sales growth   0.0% 11.3% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,576 10,598 9,247 10,929 10,620 10,445 0.0 0.0   Gross profit growth   0.0% 10.7% -12.7% 18.2% -2.8% -1.6% -100.0% 0.0%   Employees   0 0 17 17 19 18 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 11.8% -5.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,351 4,199 3,704 4,560 4,049 6,260 417 417   Balance sheet change%   0.0% 25.3% -11.8% 23.1% -11.2% 54.6% -93.3% 0.0%   Added value   1,281.9 1,935.6 619.0 1,750.9 1,648.5 1,806.6 0.0 0.0   Added value %   11.0% 14.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   234 -162 -162 -147 -57 0 0 0   Net sales trend   0.0 1.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   11.2% 15.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   11.0% 14.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.4% 18.3% 6.7% 16.0% 15.5% 17.3% 0.0% 0.0%   Net Earnings %   8.5% 11.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   8.7% 12.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   10.9% 14.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   38.3% 51.3% 15.7% 43.0% 39.6% 35.8% 0.0% 0.0%   ROI %   67.2% 89.4% 28.5% 74.4% 62.8% 53.4% 0.0% 0.0%   ROE %   77.0% 94.7% 31.8% 104.3% 74.6% 78.6% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   38.4% 45.0% 22.2% 38.9% 42.9% 29.4% 100.0% 100.0%   Relative indebtedness %   16.6% 16.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   14.2% 10.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   16.6% -20.2% 125.7% 21.4% -18.5% 47.7% 0.0% 0.0%   Gearing %   38.4% 20.2% 121.6% 39.3% 0.0% 93.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.0% 2.1% 9.3% 4.5% 8.4% 4.6% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   1.4 1.7 1.2 1.7 2.5 1.6 0.0 0.0   Current Ratio   1.4 1.7 1.2 1.7 2.5 1.6 0.0 0.0   Cash and cash equivalent   277.4 790.4 119.8 307.3 310.2 856.1 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   32.1 32.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   23.3% 28.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   784.1 1,492.1 447.3 1,737.8 2,191.8 2,200.0 0.0 0.0   Net working capital %   6.7% 11.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 36 103 87 100 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 41 108 88 100 0 0   EBIT / employee   0 0 36 103 87 100 0 0   Net earnings / employee   0 0 25 80 69 78 0 0